TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Orion Pharma A/S
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
376,745
|
320,509
|
292,286 |
Earnings before taxes |
16,349
|
14,700
|
8,382 |
Total assets |
133,469
|
124,343
|
119,208 |
Current assets |
133,169
|
124,145
|
118,978 |
Current liabilities |
56,520
|
48,841
|
53,300 |
Equity capital |
76,949
|
75,502
|
65,908 |
- share capital |
4,466
|
4,489
|
4,126 |
Employees (average) |
35
![]() |
35
![]() |
35 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
57.7%
|
60.7%
|
55.3% |
Turnover per employee |
10,764
|
9,157
|
8,351 |
Profit as a percentage of turnover |
4.3%
|
4.6%
|
2.9% |
Return on assets (ROA) | |||
Current ratio |
235.6%
|
254.2%
|
223.2% |
Return on equity (ROE) |
21.2%
|
19.5%
|
12.7% |
Change turnover |
57,878
|
2,462
|
-96,732 |
Change turnover % |
18%
|
1%
|
-25% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.